The Macular Degeneration Service is dedicated to excellence in the diagnosis and treatment of macular degeneration.
Age-related macular degeneration (AMD) is the leading cause of central vision loss in the Western world in persons over the age of 55. There are currently 15 million people in the United States with AMD. That number is expected to increase to 25 million over the next 20 years as our population ages. AMD is therefore a growing public health issue.
Carolina Eye has been a leader in AMD care and research for the last several decades. Our physicians have played a major role in the development of AMD treatments, such as macular translocation surgery, photodynamic therapy and argon laser photocoagulation. They continue to be leaders in AMD research and clinical trials.
This service offers state-of-the-art diagnostic equipment, including manual and computerized visual field testing, gonioscopy, optical coherence tomography, tonometry and optic nerve head imaging with Heidelberg retinal tomography.
A balanced diet throughout life can help protect your eyes from advanced macular degeneration. In 2001, a landmark study of the National Eye Institute showed the benefits of specific supplemental vitamins and zinc for those with macular degeneration. Use of these vitamins and minerals was shown to reduce the risk of developing advanced macular degeneration by 25 percent. This formulation of vitamins and minerals is a higher concentration than what can be obtained through diet alone or with a multivitamin. In 2013, a follow-up study showed the possible benefits adding of Lutein and Zeaxanthin to you diet. Speak with your eye care provider to determine if these vitamins and minerals may be right for you.
Carolina Eye now offers Focus Select a premium eye supplement designed to provide a daily source of essential vitamins and minerals to promote macular health. Focus Select is based on the formula utilized in AREDS 2 and provides a premium supplement which promotes macular health and is safe for smokers and non-smokers. It was developed by a group of over 400 retina specialists, representing some of the most prestigious retina institutions in the country. Focus Select is a trusted formula developed through scientific research and industry expertise.
Implantable Miniature Telescope
Patients with advanced or end-stage AMD may be candidates for the Implantable Miniature Telescope (IMT), a device that is implanted in your eye to magnify images. It is a tiny telescope that replaces your lens and works like a telephoto lens in a camera. Once implanted inside the eye, it magnifies images onto the healthy areas of the retina to help improve central or “straight ahead” vision.
Approved by the FDA, the IMT has improved vision and quality of life for many individuals with AMD, but it is not for everyone. In addition to physical requirements, it is important that candidates have realistic expectations and are willing to work with our low vision specialists to learn how to use this new vision.
The device is integral to CentraSight® a new patient care program. It is the only surgical option that improves visual acuity by reducing the impact of the central vision blind spot caused by End-stage AMD.
Are you a candidate for the IMT? IMT Patient Questionnaire.
Click here for FAQs.